Theranostics
13.3
Impact Factor
23.90
CiteScore
< 5 days
First Decision
Global reach, higher impact
Theranostics 2019; 9(26):8091-8108. doi:10.7150/thno.37204 This issue Cite
Review
Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a new perspective in nanomedicine delivery
1. Department of Medical Biophysics, University of Toronto, Toronto, ON Canada
2. MD/PhD Program, Faculty of Medicine, University of Toronto, Toronto, ON Canada
3. Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
4. Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON Canada
Citation:
Dhaliwal A, Zheng G. Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a new perspective in nanomedicine delivery. Theranostics 2019; 9(26):8091-8108. doi:10.7150/thno.37204. https://www.thno.org/v09p8091.htm
Other stylesAbstract
The enhanced permeability and retention (EPR) effect has underlain the predominant nanomedicine design philosophy for the past three decades. However, growing evidence suggests that it is over-represented in preclinical models, and agents designed solely using its principle of passive accumulation can only be applied to a narrow subset of clinical tumors. For this reason, strategies that can improve upon the EPR effect to facilitate nanomedicine delivery to otherwise non-responsive tumors are required for broad clinical translation. EPR-adaptive nanomedicine delivery comprises a class of chemical and physical techniques that modify tumor accessibility in an effort to increase agent delivery and therapeutic effect. In the present review, we overview the primary benefits and limitations of radiation, ultrasound, hyperthermia, and photodynamic therapy as physical strategies for EPR-adaptive delivery to EPR-insensitive tumor phenotypes, and we reflect upon changes in the preclinical research pathway that should be implemented in order to optimally validate and develop these delivery strategies.
Keywords: EPR-insensitive tumor phenotypes, EPR-adaptive strategies, nanomedicine
Citation styles
APA
Dhaliwal, A., Zheng, G. (2019). Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a new perspective in nanomedicine delivery. Theranostics, 9(26), 8091-8108. https://doi.org/10.7150/thno.37204.
ACS
Dhaliwal, A.; Zheng, G. Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a new perspective in nanomedicine delivery. Theranostics 2019, 9 (26), 8091-8108. DOI: 10.7150/thno.37204.
NLM
Dhaliwal A, Zheng G. Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a new perspective in nanomedicine delivery. Theranostics 2019; 9(26):8091-8108. doi:10.7150/thno.37204. https://www.thno.org/v09p8091.htm
CSE
Dhaliwal A, Zheng G. 2019. Improving accessibility of EPR-insensitive tumor phenotypes using EPR-adaptive strategies: Designing a new perspective in nanomedicine delivery. Theranostics. 9(26):8091-8108.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.